6:16 PM
 | 
Jan 22, 2013
 |  BC Extra  |  Company News

NICE recommends Eliquis

The U.K.'s NICE issued a final appraisal determination (FAD) recommending the use of Eliquis apixaban from Bristol-Myers Squibb Co. (NYSE:BMY) and partner Pfizer Inc. (NYSE:PFE) to prevent stroke...

Read the full 132 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >